u.s. bioscienc drug compani special
develop commerci anti-canc compound
grant schering-plough right hexalen wr-151327
pala rogletimid ethyol hexalen current use
treat ovarian cancer drug develop
ethyol still review food drug
administr develop control side effect
chemotherapi cancer patient
schering-plough madison n.j. lead maker
market pharmaceut health care product
